These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Cardiovascular regeneration using mesenchymal stem cells].
    Author: Mathiasen AB, Sørensen MH, Jørgensen E, Ekblond A, Kastrup J.
    Journal: Ugeskr Laeger; 2010 Sep 20; 172(38):2613-6. PubMed ID: 20920406.
    Abstract:
    Treatment with stem cells with a regenerative potential is a new form of therapy that is being studied intensively. Mesenchymal stem cells or stromal cells (MSC) are a promising source of stem cells for regenerative therapy. MSC are easy to isolate and culture, expand in vitro and have a multipotent differentiation capacity. Clinical MSC studies on patients with ischaemic heart disease have shown improved left ventricular function and perfusion and also a reduction in infarct size and symptoms. In this short review we provide a status on MSC regenerative treatment in cardiovascular disease.
    [Abstract] [Full Text] [Related] [New Search]